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Abstract
Diagnosing glaucoma progression is critical for limiting irreversible vision loss. A
common method for assessing glaucoma progression uses a longitudinal series of visual
fields (VF) acquired at regular intervals. VF data are characterized by a complex spa-
tiotemporal structure due to the data generating process and ocular anatomy. Thus,
advanced statistical methods are needed to make clinical determinations regarding
progression status. We introduce a spatiotemporal boundary detection model that
allows the underlying anatomy of the optic disc to dictate the spatial structure of
the VF data across time. We show that our new method provides novel insight into
vision loss that improves diagnosis of glaucoma progression using data from the Vein
Pulsation Study Trial in Glaucoma and the Lions Eye Institute trial registry. Sim-
ulations are presented, showing the proposed methodology is preferred over existing
spatial methods for VF data. Supplementary materials for this article are available
online and the method is implemented in the R package womblR.
Keywords: Areal wombling; Bayesian methods; Conditional autoregressive models; Dissim-
ilarity metric
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1 INTRODUCTION
Glaucoma is a leading cause of blindness worldwide, with a prevalence of 4% in the popula-
tion aged 40-80 (Tham et al., 2014). The most common form of glaucoma is primary open-
angle glaucoma (POAG). The biological basis of the disease is not fully defined, however the
most significant risk factor for POAG is elevated intraocular pressure (IOP). Elevated IOP
can be treated with eye drops, surgery, or laser. If this condition goes untreated the optic
nerve may be damaged, resulting in permanent vision loss. Since visual impairment caused
by glaucoma is irreversible and efficient treatments exist, early detection of the disease is
essential. As such, patients diagnosed with glaucoma are monitored for disease progres-
sion even if they are receiving treatment, because the role of the treatment is to slow the
progression. Determining if the disease is progressing remains one of the most challenging
aspects of glaucoma management, since it is difficult to distinguish true progression from
variability due to natural degradation or noise (Vianna and Chauhan, 2015). Numerous
techniques have been developed to monitor progression, but there is currently no consensus
as to which method is best. In this study we focus on visual field (VF) testing.
A VF test is a psychophysical procedure that assesses a patient’s field of vision. The
test results in a 2-dimensional map that represents the level of eyesight uniformly across the
retina. Glaucoma patients normally receive bi-annual VF tests and have follow-up lasting
numerous years (Chauhan et al., 2008). The collection of VF data results in a longitu-
dinal series of spatially referenced measurements that exhibit a complex spatiotemporal
structure. The spatial surface of the VF is observed on a lattice (i.e., uniform areal data),
however it is a complex projection of the underlying optic disc and exhibits anatomically
induced spatial dependencies. In particular, localized damage to the optic disc can result
in clinically deterministic deterioration across the VF (Quigley et al., 1992). Incorporat-
ing this non-standard spatial dependence structure into our methodology is a priority for
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properly analyzing these data.
There are comparable methodological complexities that arise in Alzheimer’s disease,
attention deficit hyperactivity disorder, and multiple sclerosis, all related to white-matter
connectivity of the brain (He et al., 2008; Konrad and Eickhoff, 2010). However, complex
brain imaging data are generally analyzed using point-referenced statistical models as op-
posed to areal data models (Bowman et al., 2008). The point-referenced framework has a
rich theory that accounts for non-standard spatial dependencies, mainly through the as-
sumptions of non-stationarity (Sampson, 2010) and anisotropy (Ecker and Gelfand, 2003).
Castruccio et al. (2016) model anatomical regions of interest of the brain in fMRI data
using these assumptions in a study of stroke rehabilitation, while another study accounts
for brain connectivity in Alzheimer’s patients (Thompson et al., 2004).
The literature surrounding complex spatial dependencies is less developed in the areal
data setting with spatiotemporal methods even less common. One reason for this is that
stationarity and isotropy (i.e., correlation as a function of distance alone) cannot be de-
fined for areal data due to the contrasting definition of spatial proximity between the two
frameworks. When analyzing areal data, spatial similarity is typically dictated by a local
neighborhood structure (Banerjee et al., 2003). Over time, modifications to the neighbor-
hood structure have been proposed, and in this manuscript we work within the boundary
detection framework. An extension of directional gradients from point-referenced theory
(Banerjee and Gelfand, 2006), boundary detection was originally developed to identify
boundaries on geographical maps in the context of disease mapping (Ma and Carlin, 2007).
The inherited method of modifying the local neighborhood structure provides an intricate
framework for introducing complex spatial structure on the VF. We introduce a novel spa-
tiotemporal boundary detection model that allows the underlying anatomy of the optic
disc to dictate the spatial structure of the VF across time and show that it offers new and
valuable information for improved progression detection through analysis of data from the
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Vein Pulsation Study Trial in Glaucoma (VPSG) and the Lions Eye Institute trial registry.
This paper is outlined as follows. Section 2 details the data generating mechanism for
VF data and the setting of glaucoma progression diagnostics. We briefly review spatial
boundary detection methods in Section 3. In Section 4, our newly developed statistical
methodology is described. We apply our method to a dataset of VF tests from glau-
coma patients in Section 5 and compare its performance to an existing boundary detection
method via simulation study in Section 6. We conclude in Section 7 with a discussion.
2 VISUAL FIELD DATA
The VF is the spatial array of visual sensations that the brain perceives as vision (Smythies,
1996). The most common technique for testing the VF is standard automated perimetry
(SAP) (Chauhan et al., 2008). In this study we analyze data acquired with the Humphrey
Field Analyzer-II (HFA-II) (Carl Zeiss Meditec Inc., Dublin, CA). The VF data generating
process is displayed in Figure 1. We follow a single observation throughout the figure,
presented as a diamond. In Figure 1a, a patient (the first author) is tested on a HFA-
II. SAP constructs a VF map by assessing a patient’s response to varying levels of light.
Patients are instructed to focus on a central fixation point as light is introduced randomly in
a preceding manner over a grid on the VF. As light is observed, the patient presses a button
and the current light intensity is recorded (Chauhan et al., 2008). The process is repeated
until the entire VF is tested. In the figure, the first author stares at the background of the
machine, waiting until he observes the stimulus to press the buzzer.
The HFA-II measures 54 test points, however, two of these correspond to a natural
blind spot corresponding to the optic disc, resulting in 52 informative points. The points
that correspond to the blind spot are highlighted yellow (Figure 1c). Figure 1b presents
the anatomy of the eye. The retina is a light-sensitive layer at the back of the eye that
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Figure 1: Demonstrating the VF data generating mechanism, a) A patient (the first author) par-
ticipates in a VF examination. b) The HFA-II stimulus is absorbed by the retina and transmitted
through the optic disc, and along the optic nerve to the brain. c) Each VF test point corresponds
to a location on the underlying RNFL. d) The corresponding nerve fiber enters the optic disc at
77◦. e) Each VF test produces a map that shows the intensity a stimulus is detected at each test
location. The gray locations represent the blind spot. f) Over time the patient accrues VF tests.
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absorbs stimulus from the HFA-II and transmits information to the brain through the optic
disc along the optic nerve. The optic nerve is a bundle of more than one million fibers that
carry visual information in the form of electrical signal from the retina to the brain. The
retinal nerve fiber layer (RNFL), Figure 1c, is made of retinal ganglion cell (RGC) axons.
All the axons converge at the optic disc, which is the departure point of the optic nerve.
These RGC axons are responsible for encoding visual information. The ganglion cells
disperse across the retina, but are mostly concentrated in the center of the retina, and
use photoreceptors to transmit information to the brain along their axons (Davson, 2012).
Both the RGCs and their axons may die progressively as a result of elevated IOP. In
particular, damage to specific regions of the optic disc corresponds to loss of RGCs whose
axons enter the damaged region. Thus, vision loss across the VF and the corresponding
damage to the optic disc are the result of the death of RGCs and their axons. Furthermore,
correlation between two test points on the VF is dependent on the spatial proximity that
their underlying nerve fibers enter the optic disc. This indicates that variability in the
neighborhood structure of the VF is possibly indicative of progression. The nerve fibers
(not to be confused with the thicker and more sparse blood vessels) are shown extending
throughout the retina with the VF test points represented by black dots.
Each test location has underlying fibers that track across the RNFL and enter the optic
disc at a particular angle. Garway-Heath et al. (2000) studied the relationship between
the VF test points and the underlying RNFL. They quantified the relationship between
the VF and optic disc by estimating the angle that each test location’s underlying fiber
enters the optic disc, measured in degrees (◦). The measure ranges from 0-360◦, where 0◦ is
designated at the 9-o’clock position (right eye) and angles are counted counter clockwise.
The Garway-Heath angle for the example location is 77◦ (Figure 1d).
In the course of a VF test all 52 informative locations are assessed, resulting in a grid
of test values (Figure 1e). The two locations corresponding to the blind spot are gray.
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SAP measures the differential light sensitivity (DLS) across the VF. The measurement
represents a contrast between the background of the machine, normally white, and the
light stimulus. The intensity of the stimulus is initially similar to the background, but
as the intensity increases the contrast grows and the probability of detecting the stimulus
increases. The intensity of the stimulus is measured in Apostilbs (asb), where larger values
represent a greater intensity. The HFA-II is capable of outputting intensities ranging from
one (similar to the background) to 10,000 asb. All stimuli that are not detected by 10,000
asb are censored, due to the constraints of the machine. In practice, these intensities are
converted to decibels (dB), where dB = 40 − 10 log10 (asb). This inverts the scale, such
that DLS values near 40 indicate good vision, while values near zero represent possible
blindness. In the course of monitoring a patient with glaucoma, VF testing is performed
on a regular basis and a longitudinal series of VFs is obtained (Figure 1f).
3 SPATIAL BOUNDARY DETECTION
VF data exhibit a complex spatiotemporal structure that is characterized by localized
spatial dependencies dictated by the underlying anatomy of the optic disc. These data are
generated over a lattice, a subset of areal data in spatial literature. In spatial statistics,
the foundational assumption states that dependence between observations weakens as the
distance between locations increases (Gelfand et al., 2010). In areal data models, this
assumption often manifests through Gaussian Markov random fields (GMRF) that induce
neighborhood dependence across the region (Geman and Geman, 1984). A common GMRF
is the conditional autoregressive (CAR) process (Besag, 1974).
The CAR model achieves spatial smoothing through random effects, ϕi at location i for
i = 1, . . . , n, with spatial structure defined through the set of neighborhood adjacencies,
{wij}. These adjacencies are fixed, such that wij = 1(i ∼ j), where 1(·) is the indicator
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function and i ∼ j is the event that locations i and j share a border (wii = 0 for all i).
This specification induces an elegant conditional distribution for each random effect. We
present a general form of the CAR process originally introduced by Leroux et al. (2000),
ϕi|ϕ−i, µ, τ 2 ∼ N
(
ρ
∑n
j=1wijϕj + (1− ρ)µ
ρ
∑n
j=1wij + 1− ρ
,
τ 2
ρ
∑n
j=1wij + 1− ρ
)
, (1)
where ϕ−i = (ϕ1, . . . , ϕi−1, ϕi+1, . . . , ϕn)
T . Note that setting ρ = 1 reduces Equation 1 to
the standard intrinsic CAR process. The mean is a weighted average of the neighbors with
variance decreasing inversely with the number of neighbors. The standard CAR model
provides an attractive representation and is flexible in its ability to model smooth spatial
processes. However, it can be limited in settings where spatial structure is fragmented into
localized regions due to {wij} being fixed. In the areal data setting, a flexible class of
models called boundary detection can be used to remedy this issue (Banerjee et al., 2003).
Boundary detection was originally explored by Womble (1951), but has gained a niche
in the context of disease mapping. The motivation for boundary detection is to identify
regions on the spatial surface where there are sharp changes in the response value (Jacquez
and Greiling, 2003). In disease mapping, these boundaries can take many forms, for ex-
ample geographic obstacles such as mountain ranges or socioeconomic boundaries caused
by pockets of increased poverty. Standard methods attempt to control for disjoint spatial
regions by including covariates in the mean structure of the CAR process. This technique
can be effective in producing highly variable spatial surfaces, but is limited in producing
truly localized spatial smoothing (Banerjee et al., 2003). Boundary detection improves on
this naive approach by carefully considering the form of the adjacencies.
Initially boundary detection methods were parameterized for use in disease mapping,
defining boundaries as a function of the difference in standardized incidence ratios (Lu
and Carlin, 2005). This method is limited, since it can be difficult to have knowledge of
boundaries a priori and does not generalize outside of disease mapping. Numerous meth-
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ods in the boundary detection literature treat the adjacencies as random variables and
construct hierarchical models to estimate the adjacency matrix (Lu et al., 2007; Ma and
Carlin, 2007), and even provide extensions to the spatiotemporal setting (Rushworth et al.,
2017). However, inference from these models can be highly sensitive to prior specifications
on certain parameters (Li et al., 2015). Furthermore, these methods introduce (n)(n−1)/2
additional random variables leading to potential identifiability issues. Li et al. (2011) pro-
posed another class of methods that enumerate all possible permutations of the adjacencies
in parallel models, using the Bayesian information criterion to choose between them. This
class of methods was formalized when Lee et al. (2014) introduced a novel joint prior distri-
bution for the spatial random effects and adjacency matrix. This prior has been extended
to spatiotemporal models (Lee and Mitchell, 2014).
A final class of methods models the adjacencies using dissimilarity metrics. The method
introduced in Lee and Mitchell (2011) generalizes the form of Equation 1 to allow for the
adjacency weights to be modeled as a function of a small number of regression parameters,
α = (α1, . . . , αq)
T . According to Lee and Mitchell (2011), “boundaries in the risk surface
are likely to occur between populations that are very different because homogeneous popu-
lations should have similar risk profiles”. They define q non-negative dissimilarity metrics
zij = (zij1, . . . , zijq)
T , where zijk = |zik− zjk| for k = 1, . . . , q. The q covariates, zik at loca-
tion i, drive detection of boundaries and are characterized by their importance in defining
the neighborhood structure. The choice of q is problem specific and based on the availabil-
ity of useful explanatory information for describing the boundaries. The adjacencies are
modeled as follows,
wij (α) = 1(i ∼ j)1
(
exp
{−zTijα} ≥ 0.5) (2)
where each αk is constrained to be non-negative so that a larger dissimilarity metric indi-
cates a higher likelihood of a boundary (or zero weight). In this model, ρ is fixed at 0.99
to force the spatial correlation structure to be determined locally by {wij (α)}, rather than
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globally by µ. This form has many appealing properties that make it amenable to bound-
ary detection. In particular, if there are no adjacencies (i.e., wij(α) = 0 for all i 6= j) the
conditional mean and variance are still defined. The method proposed by Lee and Mitchell
(2011) provides a parsimonious framework for introducing localized smoothing.
4 METHODS
Following the approach of Lee and Mitchell (2011), we propose modeling localized spatial
correlation through a set of weights {wij (αt)} as a parsimonious function of dissimilarity
metrics and their regression parameters. However, we propose extending the framework to
account for spatiotemporal localized smoothing and therefore define αt = (αt1, . . . , αtq)
T ,
for t = 1, . . . , ν. With appropriate temporal dependency structures in place, this specifica-
tion allows for localized smoothing in instances of true temporal correlation. Inference for
this model is based on Markov chain Monte Carlo (MCMC) simulation, and a description
of the algorithm is given in the online supplementary materials. Spatiotemporal models
are computationally intensive, so the MCMC algorithm is implemented using Rcpp (Ed-
delbuettel et al., 2011) and is available from the R package womblR (R Core Team, 2016).
4.1 Observational Model
We begin by describing our new methodology generally before applying it to VF data in
Section 5. Let Yit denote an observation from spatial location i at time t, i = 1, . . . , nt, for
t = 1, . . . , ν. The number of locations can vary over time. Define ϕt = (ϕ1t, . . . , ϕntt)
T ,
with ϕ−it missing the i
th entry. The observational model is given by,
Yit|ϑit, ζ ind∼ f(Yit|ϑit, ζ) for i = 1, . . . , nt, t = 1, . . . , ν, (3)
g(ϑit) = ϕit,
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ϕit|ϕ−it, µt, τ 2t ,αt ind∼ N
(
ρ
∑nt
j=1 wij (αt)ϕjt + (1− ρ)µt
ρ
∑nt
j=1wij (αt) + 1− ρ
,
τ 2t
ρ
∑nt
j=1wij (αt) + 1− ρ
)
.
The parameter ϑit describes the distribution of Yit and our novel spatiotemporal random
effect, ϕit, is introduced as a linear predictor of g(ϑit), with g(·) a link function. Finally, ζ is
a vector of variance (or nuisance) parameters, for example the over-dispersion parameter in
the negative binomial distribution. This modeling framework is general and accommodates
generalized linear mixed models (GLMM). The GLMM setting can be obtained by setting
ϑit = E[Yit|ϑit]. Due to the general specification, our methodology can be used to induce
spatiotemporal localized smoothing in a general areal data setting, such as disease mapping.
The random effect for ϕit represents an extension of the Lee and Mitchell (2011) speci-
fication with temporally referenced parameters, µt, τ
2
t , and αt (referred to as observational
level parameters). The ρ parameter acts as a gauge of present spatial variation, where
ρ = 0 corresponds to global independence and ρ → 1 implies strong spatial correlation.
In the same vein as Lee and Mitchell (2011), we fix ρ = 0.99 to guarantee that spatial
correlation can be determined locally by the set of weights {wij(αt)}. We fully explore the
impact of this decision through simulation as described in Section 5.6 and in the online
supplementary materials. Overall, we find that the results are robust to this choice.
The conditional distributions of the random effect can be written jointly using Brook’s
Lemma (Banerjee et al., 2003), ϕt|µt, τ 2t ,αt ind∼ MVN
(
µt1nt , τ
2
t Q (αt)
−1) , t = 1, . . . , ν,
where Q (αt) = [ρW
∗ (αt) + (1− ρ)Int ], and 1n and In are an n dimensional column of ones
and identity matrix, respectively. The matrix W∗ (αt) has diagonal elements w∗ii (αt) =∑nt
j=1wij (αt) and off-diagonal elements w
∗
ij (αt) = −wij (αt).
4.2 Neighborhood Model
We use a similar framework as Lee and Mitchell (2011) to model the adjacency weights by
writing them as a function of dissimilarity metrics, zij. The weights are defined as follows,
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wij (αt) = 1(i ∼ j) exp
{−zTijαt} . (4)
Unlike the original Lee and Mitchell (2011) specification (Equation 2), the weights are not
forced to be binary. We do specify the components of αt to be non-negative, forcing the
adjacencies in the open unit interval. These constraints on αtk yield intuitive interpretations
at extreme values. As αtk →∞ the adjacencies become zero, resulting in an independence
model, while αtk → 0 reduces the adjacencies to a standard CAR process (Equation 1). This
new specification changes how neighbors share information. It is best understood through
the conditional mean from Equation 1, which becomes a weighted average of neighbors
under our new definition of an adjacency, versus a simple average.
4.3 Temporal Model
From the joint specification of the random effects, we see that spatial structure is introduced
through the covariance of ϕt at each time point and there is conditional independence
(ϕt1 ⊥ ϕt2 |µt, τ 2t ,αt : t = t1, t2). To induce temporal dependence between the ϕt, we
specify a separable temporal structure on the observational level parameters. Define,
θ = [θ·1 · · ·θ·ν ] =

θ1·
θ2·
θ2+1·
...
θ2+q·

=

µ1 · · · µν
log (τ1) · · · log (τν)
log (α11) · · · log (αν1)
...
...
log (α1q) · · · log (ανq)

.
Using properties of the vectorization function, vec(·), and the Kronecker product, ⊗, a
separable process is specified such that
vec (θ) |δ,T, φ ∼ MVN (1ν ⊗ δ,Σ (φ)⊗T) . (5)
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This process yields elegant interpretations for the row and column moments of θ. From
the moments, we see that δ is a constant that corresponds to the mean of the observational
level parameters at time t. The matrix T can be interpreted as the local covariance of the
observational level parameters at each time t.
Finally, the correlation matrix, Σ(φ), represents the temporal correlation of each ob-
servational level parameter over time. Due to the properties of the separable covariance,
each of the observational level parameters has the same temporal structure dictated by the
form of Σ(φ). The form of Σ(φ) is general such that any standard temporal correlation
function may be specified (e.g., exponential or first order autoregressive). The parameter
φ acts as a temporal tuning parameter describing the strength of correlation across time
and can be interpreted within the context of each specific temporal structure.
4.4 Specifying Hyperprior Distributions
In order to complete the model specification, we define hyperprior distributions for the
introduced parameters such that
δ ∼ MVN(µδ,Ωδ), T ∼ Inverse-Wishart(ξ,Ψ), φ ∼ Uniform(aφ, bφ).
The choice of the entries in µδ can be informative or non-informative depending on the con-
text and user. It is important to judiciously consider the entries of Ωδ. For simplification,
we detail a situation where Ωδ is diagonal, Ωδ = Diag(1000, 1000, υ1, . . . , υq). The entries
in Ωδ that are of importance are those that correspond to log(αtk), since the large vari-
ances for µt and log(τt) induce approximately flat priors. More care is needed in specifying
υ1, . . . , υν . These hyperprior variances are chosen for purposes of regularization, in order to
encourage log(αtk) to be in a realistic range. Regularization is a common use of Bayesian
priors (Gelman and Shalizi, 2013). In particular, these variances are chosen so that αtk do
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not become larger than α∗k, such that [α
∗
k : exp{−α∗kzk} = 0.5] with zk =min
i,j
{zijk}. This
condition comes from Equation 4, where we isolate each dissimilarity metric individually.
For our prior on T, we use an inverse-Wishart distribution with degrees of freedom
ξ = (q + 2) + 1 and scale matrix, Ψ = Iq+2. This prior is appealing since it induces
marginally uniform priors on the correlations of T and allows for the diagonals to be weakly
informative (Gelman et al., 2014). Finally, we specify the hyperprior distribution for the
temporal tuning parameter φ for correlation structures with one parameter. The bounds
for φ cannot be specified arbitrarily since it is important to account for the magnitude of
time elapsed. We specify the following conditions for finding the bounds, [aφ : [Σ(aφ)]t,t′ =
0.95, |xt−xt′| = xmax] and [bφ : [Σ(bφ)]t,t′ = 0.01, |xt−xt′| = xmin], where xmin and xmax are
the minimum and maximum temporal differences between visits. These conditions state
that the lower bound of φ is small enough so that the greatest length of time between
time points can yield a correlation of 0.95 and the upper bound is set so that the shortest
length of time between time points can reach 0.01. These conditions were specified so that
φ can dictate a temporal correlation close to independence (φ → bφ) or strong correlation
(φ→ aφ), resulting in a weakly informative prior distribution.
4.5 Prediction
Once posterior samples have been obtained, prediction is often a priority. In particular, ob-
taining samples from the posterior predictive distribution (PPD) is of interest, f (Yν+1|Y),
where Yt = (Y1t, . . . , Yntt)
T and Y = (Y1, . . . ,Yν)
T . We express the PPD as an integral∫
Ω
f (Yν+1|Ω,Y) f (Ω|Y) dΩ and then further partition the integral,∫
Ω
f
(
Yν+1|g−1
(
ϕν+1
)
, ζ
)︸ ︷︷ ︸
1
f
(
ϕν+1|θ·ν+1
)︸ ︷︷ ︸
2
f (θ·ν+1|θ, δ,T, φ)︸ ︷︷ ︸
3
f (ζ,θ, δ,T, φ|Y)︸ ︷︷ ︸
4
dΩ, (6)
where Ω = (ϕν+1,θ·ν+1, ζ,θ, δ,T,φ). The convenient form of Equation 6 is a function of
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four known densities that are defined as a consequence of the methodology introduced in
Section 4. As such, the PPD can be obtained through composition sampling (Tanner, 1996).
This theory is presented with one future time point, but is easily generalized to multiple.
Full prediction theory details are presented in the online supplementary materials.
5 ANALYSIS OF VISUAL FIELD DATA
5.1 Study Data
In this study, we source data from the VPSG and the Lions Eye Institute trial registry,
Perth, Western Australia. The dataset contains 1,448 VFs from 194 distinct eyes (98
patients in total). Three of the eyes had no clinical assessment of progression and are
discarded, yielding 191 series of VFs for analysis. All of the subjects have some form of
POAG. The mean follow-up time for participants is 934 days (2.5 years) with an average
of 7.4 tests per subject. The progression status of each eye was determined by a group of
expert clinicians. Although there is no consensus gold standard for diagnosing progression,
there is precedent for treating clinician expertise as a gold standard when introducing
new analytic models (Betz-Stablein et al., 2013; Warren et al., 2016). Every VF series is
diagnosed as progressing based on the clinical judgment of two independent clinicians. In
the case that the two clinicians disagree, a third clinician is consulted (occurred for only 13
VF series). In our study we have 141 (74%) stable and 50 (26%) progressing patient eyes.
For a detailed description of the data, please refer to Betz-Stablein et al. (2013).
5.2 Accounting for Zero-Truncation
We apply our newly developed methodology to a longitudinal series of VFs. From Section 2,
we know that VF testing machinery does not allow observations below 0 dB, and therefore
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any zero measurement represents a potentially censored observation. This motivates the
use of a Tobit model (Tobin, 1958), in which there is precedent in glaucoma progression
research (Betz-Stablein et al., 2013; Bryan et al., 2015).
Define the observed DLS, Yit, at VF location i with i = 1, . . . , 52 and visit t with
t = 1, . . . , ν. There are 52 VF locations excluding the blind spot and ν is the number of
visits a patient accrues and is patient specific. To induce the Tobit model, define g(ϑit) = ϕit
with identity link and specify,
f(Yit;ϑit) = P (Yit = x|ϑit) = 1(x = 0)1(ϑit ≤ 0) + 1(x = ϑit)1(ϑit > 0), x ≥ 0.
This specification induces the standard Tobit model, Yit = max {0, ϑit}, where ϑit is an
underlying normally distributed latent process.
5.3 Creating a Dissimilarity Metric
We specify a dissimilarity metric based on the Garway-Heath angles defined in Section 2,
since we know that correspondence between VF test locations and their underlying nerve
fibers is important in determining local neighborhood structure. Figure 2 displays the
dissimilarity metric. It shows that two locations on the VF may be neighbors, but can still
be dissimilar in terms of the Garway-Heath angles. Interestingly, a pattern emerges across
the VF that mirrors the RNFL (left in Figure 2). In particular, the locations that are
separated by the superior and inferior regions are separated by nearly 180◦ and the flow of
spatial dependency emulates the nerve fibers.
Formally, we define zi as the Garway-Heath angle for location i. Then, the dissimilarity
metric between locations i and j is zij = ||zi − zj||. We use the following distance metric,
||x− y|| = min{|x− y|, 360−max{x, y}+ min{x, y}}. This metric calculates the minimum
difference in Garway-Heath angles on the arc of the circular optic disc. We define our
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Garway−Heath dissimilarity metric
 across the visual field
0
45
90
135
180
Degree (°)
268 262 252 245
264 274 281 275 260 246
271 285 291 296 298 283 253 229
278 287 291 298 312 329 318 218
83 76 68 55 34 11 13 167
85 78 66 56 48 60 95 136
88 81 77 80 93 112
93 95 100 108
Figure 2: Demonstrating the Garway-Heath dissimilarity metric across the VF (right). The angles
are defined as the degree at which the underlying nerve fiber enters the optic disc for each location.
The edges and corners are shaded to represent the distance between bordering locations on the
VF, where darker shading represents a larger distance. The RNFL is displayed to demonstrate
the similarity of the pattern that appears on the VF by using the Garway-Heath angles (left).
dissimilarity parameter at time t as αtGH , since we only use a single dissimilarity metric.
We allow the event 1(i ∼ j) to include both edges and corners (i.e., a queen specification).
5.4 Model Estimation
To finalize the model, we specify the temporal correlation structure and hyperparameters.
We define an exponential correlation structure, such that [Σ(φ)]t,t′ = exp{−φ|xt − xt′ |}
where xt is the number of days at visit t after the initial visit, with x1 = 0 for each patient.
Based on the criterion in Section 4.4 for the Garway-Heath dissimilarity metric, we specify
υ1 = 1. Then we set Ωδ = Diag(1000, 1000, 1) and µδ = (3, 0, 0). For complete details on
the implementation of the model, see Section 1 of the online supplementary materials.
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5.5 Diagnosing Glaucoma Progression
5.5.1 Establishing a Novel Diagnostic Metric
The methodology presented in Section 4 provides a novel framework for studying glaucoma
progression. Since progression is characterized by worsening disease severity over time, we
propose using a function of αtGH that can quantify this variation. We suggest using the
posterior mean of the coefficient of variation (CV) of αtGH for t = 1, . . . , ν. The CV is
the ratio of the standard deviation and mean and is an ideal summary metric, because it
accounts for the variability in a parameter while standardizing by its mean, allowing it to be
comparable over populations. This metric is novel clinically as αtGH does not describe mean
trend in DLS over time, but rather is representative of optic disc damage and changes in the
spatial covariance structure across time. We refer to our metric based on the spatiotemporal
(ST) model as “ST CV”. In Figure 3, we display posterior mean estimates of αtGH over
time for all patients, subset by progression status. The figure suggests that there is more
variability in the estimates across time for the progressing patients generally, and that there
is not a clear trend in the estimates across time for either group. This further motivates a
metric like CV to quantify general variability across time for diagnostic purposes.
In order to assess the novelty of our metric, we compare it to two metrics that aim
to be representative of a class of standard VF trend-based methods. Trend-based VF
diagnostic techniques can be grouped in two categories, global and point-wise, and study
associations between VF changes and progression (Vianna and Chauhan, 2015). We define
the global metric “Mean CV” as the CV of the VF wide mean of DLS at each visit. If
the patient is stable, the means should be similar at each visit and the CV of the metric
should be near zero. On the other hand, a progressing patient will have varying means
at each visit and the CV should increase as visits accrue. We also compare our model to
a commonly used point-wise linear regression (PLR) method. The progression metric is
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Figure 3: Posterior mean estimates of αtGH plotted across time for all patients, subset by pro-
gression status defined at the end of the study.
defined as the minimum p-value for the slope parameter from separately run simple linear
regression analyses across all VF locations, where observed DLS is the dependent variable
and time from first visit is the independent variable (Smith et al., 1996). Using both “Mean
CV” and PLR as comparators is far-reaching, as global methods are generally more robust,
while point-wise methods identify local changes in visual ability.
To assess the diagnostic capability of our metric, we construct logistic regression mod-
els regressing various metrics on the clinical assessment of progression. We compare our
method to “Mean CV”, PLR, and also the posterior mean CV of αtGH from the Lee and
Mitchell (2011) model, where αtGH is estimated independently at each visit. We refer
to this metric as “Space CV”. To obtain “Space CV”, we apply the Lee and Mitchell
(2011) methodology with a Tobit likelihood. Thus, the appreciable differences between
the two models that produce “Space CV” and “ST CV” are the definition of the weights,
cross-covariance, and temporal correlation structure for the observational level parameters.
In Table 1 we present the results from the logistic regression analyses using a significance
level of 0.05. Each predictor is standardized in order to facilitate comparisons of the
19
Table 1: Assessing the diagnostic capability of VF metrics. Each metric is regressed against the
clinical assessment of progression using a logistic regression model with the slope estimates being
displayed (∗significance level of 0.05). “Mean CV” is the CV of the VF wide mean of DLS at each
visit, PLR is the minimum p-value of the location specific regression slopes, and “Space CV” and
“ST CV” represent the mean posterior CV of αtGH from the Lee and Mitchell (2011) and our
spatiotemporal models, respectively. Each of the metrics are standardized.
Metrics Estimate Std. Error z value Pr(>|z|)
Mean CV 0.40 0.16 2.55 0.011∗
PLR -0.59 0.25 -2.37 0.018∗
Space CV -0.07 0.17 -0.41 0.680
ST CV 0.39 0.16 2.44 0.015∗
different metrics. We can see that as expected “Mean CV” and PLR are significantly
associated with glaucoma progression, with p-values of 0.011 and 0.018, respectively. For
“Mean CV”, the estimated slope coefficient of 0.40 indicates that as a patient’s “Mean CV”
increases, their risk of progression increases. For PLR, a smaller minimum p-value suggests
an increased risk of progression (estimated slope coefficient of -0.59). Based on the glaucoma
literature, we would expect trend-based methods such as “Mean CV” and PLR to have good
discriminatory capability between stable and progressing eyes. It was less clear for our new
metrics dependent on αtGH . We see that “Space CV” is not significantly associated with
glaucoma progression with a p-value of 0.680, while “ST CV” is significantly associated
with a p-value of 0.015. This result is encouraging, yet surprising, since the models are
similar and illuminates their differences in the VF data setting. However, for this newly
defined metric to be impactful, we must verify that it is explaining a novel pathway in
glaucoma progression, independent of existing metrics.
In order to assess whether “ST CV” provides novel diagnostic capabilities, we explore
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the correlation between the metrics. In Figure 1 of the online supplementary materials,
we show pairwise correlation plots. We also present Pearson correlation estimates (ρ) and
p-values from the hypothesis test: H0 : ρ = 0, H1 : ρ 6= 0. “ST CV” is uncorrelated
with both “Mean CV” and PLR with estimated correlations of 0.06 and 0.11, respectively,
and large p-values. This result has important implications; indicating that in addition to
being highly predictive of progression, “ST CV” is uncorrelated with the standard trend-
based metrics. This suggests that “ST CV” and the trend-based metrics can be used in
conjunction in order to diagnose progression. Finally, the estimated correlation between
“Space CV” and “ST CV” is 0.48 and the p-value is highly significant (< 0.001), which
is not surprising since “Space CV” and “ST CV” are estimating the same quantity. It is,
however, interesting that these two metrics have such different associations with glaucoma
progression (see Table 1). When “Space CV” was calculated with continuous weights
this association did not change (p-value: 0.326, not included in Table 1), indicating the
importance of temporal correlation and cross-covariance for properly modeling VF data.
Presumably due to our enhanced methodology, “ST CV” is more precisely estimating the
CV of αtGH by smoothing the αtGH and eliminating temporal noise and cross-covariance
dependencies. To formalize this hypothesis a simulation study is designed in Section 6.
5.5.2 Extension to the Clinical Setting
Having demonstrated the novelty of using variability in the boundary detection parame-
ter as a progression diagnostic, we now establish its clinical utility. We combine the two
trend-based metrics into a composite model that represents an ideal synthesis of global
and local methods. This metric includes “Mean CV” and PLR and their interaction. We
then compare the changes in operating characteristics after separately adding “Space CV”
and “ST CV” to this composite model, including the main effect and pairwise interactions.
These results are presented in Table 2, where summary statistics include the Akaike in-
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Table 2: Operating characteristics for diagnostic metrics. P-values assess statistical significance
of improvement over the combined trend-based metric (Mean CV & PLR) for, 1) additionally
included regression parameters (using a nested likelihood ratio test), 2) AUC, and 3) pAUC.
AIC AUC pAUC p-value1 p-value2 p-value3
Mean CV & PLR 209.81 0.68 0.21 − − −
Mean CV & PLR + Space CV 213.46 0.70 0.22 0.503 0.196 0.410
Mean CV & PLR + ST CV 204.46 0.74 0.29 0.010 0.042 0.059
formation criterion (AIC), area under the receiver operating characteristic (ROC) curve
(AUC), and the partial AUC (pAUC). Here, pAUC is limited to the clinically significant
region of specificity of 85-100% (Zhu et al., 2014).
The results indicate the clinical importance of “ST CV”, producing optimal values of
AIC, AUC, and pAUC. Furthermore, adding “ST CV” produces statistically significant
improvements over the composite trend-based model in terms of the additional predictors,
and both AUC and pAUC (although at the α = 0.10 level for pAUC). Meanwhile, there are
no improvements in the operating characteristics when adding “Space CV”, which is also
confirmed when investigating the ROC curves (Figure 4a). In Figure 4a, it is clear that
the inclusion of “ST CV” increases the discriminatory ability of the composite trend-based
model, in particular within the clinically significant region, left of the dashed line.
In addition to operating characteristics calculated at the end of the study, we are also
interested in the diagnostic performance of each metric in earlier stages of the disease,
where accurate discrimination is more important for preserving a patient’s visual ability.
In Figure 4b, a smoothed LOESS trajectory of pAUC is presented for each of the models in
Table 2 for the first 4.5 years of follow-up. This analysis reflects a true clinical setting where
data are analyzed as they are collected for a patient over time. We calculate “Mean CV”,
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Figure 4: Demonstrating the performance of diagnostic metrics: a) ROC curves for the com-
bined trend-based metric (Mean CV & PLR), including the addition of “Space CV” and “ST
CV” (clinically meaningful region to the left of dashed line), b) pAUC in the initial years from
baseline visit (estimates are presented as smooth LOESS curves and the dashed line indicates
no discrimination), c) boxplots of the predicted probabilities of progression presented by disease
status over time as defined at the end of the study period.
PLR, “Space CV”, and “ST CV” for each patient during each visit. Then, using the fitted
logistic regression models from the end of the study, we calculate predicted probabilities of
VF progression. Finally, these probabilities are converted into binary disease progression
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diagnoses based on probability cutoffs obtained from the full study data. We forgo the
commonly used Youden’s index (which maximizes sensitivity and specificity), for a criteria
that forces specificity to be in the clinically significant range, while maximizing sensitivity.
These results indicate that the improvement in operating characteristics attributed to
“ST CV” begins early during the follow-up period, in particular for pAUC. This result
establishes that “ST CV” is clinically useful, and further enforces the importance of the
introduced methodology as “Space CV” is incapable of improving operating characteristics
during the same time period. In addition, Figure 4c presents boxplots of the predicted
probabilities at half-year intervals, by progression status as defined at the end of the study.
In Figure 4c, there is a clear separation between the progressing and non-progressing pa-
tients’ predicted probabilities of progression beginning around 1.5 years after baseline visit.
This separation is more pronounced with the addition of “ST CV”.
5.6 Sensitivity Analyses
In the online supplementary materials, we present a number of sensitivity analyses and an
additional simulation study to explore various modeling assumptions, including hyperpa-
rameter choices, the correlation structure, the bounds of φ, and misspecification of ρ and
the dissimilarity metric. Overall, we find that the results are robust to these assumptions.
For full details on these analyses, please see the online supplementary materials.
6 MODEL PERFORMANCE SIMULATION
A simulation study is designed to assess the performance of the proposed model in the
presence of temporal dependence and cross-covariance. We focus on the estimation of CV
of αtGH , since we propose using this posterior distribution in diagnosing progression.
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In order to understand the gains of using our methodology in the presence of temporal
correlation and cross-covariance dependence, we design a simulation study comparing the
spatial model of Lee and Mitchell (2011), referred to as Space, and our spatiotemporal
method (ST). We simulate data based on a set of known hyperparameters and then estimate
the posterior mean of the CV of αtGH using both models, comparing the estimates to the
known truth using bias, mean squared error (MSE), and empirical coverage (EC). The
simulation is designed to explore model performance in a typical patient from our study
data. As such, we fix the true hyperparameters in the simulation study to the posterior
means obtained from Section 5 for an average patient. Here an average patient is one whose
posterior mean estimates are average amongst all patients. The true hyperparameters used
in the simulation study are as follows,
δ =

2.446
0.070
0.974
 , T =

0.820 0.004 −0.028
0.004 0.380 −0.191
−0.028 −0.191 0.840
 , φ = 0.163.
Simulation settings are developed to incrementally understand the impact of the cross-
covariance, T, and temporal correlation, Σ(φ). To facilitate this analysis, Equation 5
is utilized. Define TDiag = Diag(T), such that TDiag has zeros on the off-diagonal and
φI = 100 (note that a large φ for the exponential correlation implies temporal indepen-
dence). The simulation settings are as follows with the data generating covariance given in
parentheses, A: no temporal correlation, no cross-covariance (Σ (φI)⊗TDiag), B: no tempo-
ral correlation, cross-covariance (Σ (φI)⊗T), C: temporal correlation, no cross-covariance
(Σ (φ)⊗TDiag), D: temporal correlation, cross-covariance (Σ (φ)⊗T). Finally, we must
specify the days and number of VF visits. To obtain the visit days, we sampled from a
Poisson distribution with rate parameter equal to the average difference in days between
VF visits (rate = 117.25 days). We present the simulation at the median (7) and maximum
(21) number of visits in our study data.
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Table 3: Results from simulation study estimating the posterior mean of the CV of αtGH in setting
A: no temporal correlation, no cross-covariance, B: no temporal correlation, cross-covariance, C:
temporal correlation, no cross-covariance, and D: temporal correlation, cross-covariance. Each
setting is also implemented for the median (7) and maximum (21) number of VF visits. Each
reported estimate is based on 1,000 simulated datasets.
# Visits
7 (Median) 21 (Maximum)
Setting Model Bias MSE EC Bias MSE EC
A ST 0.032 0.107 0.97 0.023 0.084 0.95
Space 0.102 0.111 0.87 0.174 0.098 0.81
B ST 0.047 0.125 0.96 0.034 0.101 0.95
Space 0.119 0.120 0.80 0.250 0.176 0.68
C ST -0.113 0.088 0.97 0.002 0.037 0.98
Space -0.306 0.172 0.51 -0.182 0.088 0.60
D ST -0.103 0.085 0.98 0.015 0.060 0.98
Space -0.299 0.172 0.51 -0.169 0.087 0.59
For each simulation setting, we generate 100 values of θ and then use each θ to simulate
10 datasets. This yields 1,000 simulated datasets for each of the simulation settings. In
Table 3, the bias, MSE, and EC are presented for the two models across all settings and
at the median and maximum number of visits. We begin by noting the average (across
all settings) simulation standard errors of the bias (0.223, 0.063), MSE (0.039, 0.028) and
EC (0.141, 0.013) for the space and spatiotemporal models, respectively. In general the
spatiotemporal model has smaller standard errors than the space model, indicating less
variability in estimation across the simulated datasets.
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The bias results suggest that our spatiotemporal model produces an estimator of CV
with bias closer to zero than the spatial model on average across all settings. In the settings
with no temporal correlation (i.e., A and B) the MSE is quite similar between the models,
except for Setting B where the maximum number of visits is considered. In this setting, the
MSE is lower for the spatiotemporal model, revealing the importance of the cross-covariance
for properly estimating the posterior mean of the CV of αtGH . In all other settings, the
estimated MSEs for the spatiotemporal model are smaller than for the spatial model, with
the largest differences seen in Settings C and D for the median number of visits.
The EC is the proportion of the time that the estimated Bayesian credible intervals
contain the true CV value. We define the nominal coverage as 95%. The EC results favor
the spatiotemporal model across all settings. The spatial model has an EC of 0.87 and 0.81
in setting A for the median and maximum settings, respectively. This is the most ideal
setting for the spatial model, because it was the setting in which the model was introduced
(although within the context of disease mapping). The EC deteriorates in the spatial model
as cross-covariance and temporal structure are introduced in the simulated data, falling as
low as 0.51, while the spatiotemporal model performs consistently.
7 DISCUSSION
In this paper, we proposed a modeling framework for incorporating local neighborhood
structure into complex spatiotemporal areal data. Based on this framework we developed
an innovative and highly predictive diagnostic of glaucoma progression that outperformed
the spatial-only model. Although motivated by VF data, the methodology was intro-
duced in a general manner that permits the model to be applied in broad areal data
settings, including disease mapping and more generally GLMM. The methodology is built
upon theory in boundary detection literature, utilizing a Bayesian hierarchical modeling
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framework for inference. We extended the spatial-only method introduced by Lee and
Mitchell (2011), that elegantly introduced a dissimilarity metric in a parsimonious frame-
work. Our method allows for the local neighborhood structure to adapt over time as a
function of changing dissimilarity metric parameters. Furthermore, the temporal correla-
tion and cross-covariance are accounted for, eliminating known sources of excess variability.
This parsimonious method induces non-standard local spatial surfaces in areal data that
are capable of mirroring complex processes, such as the surface of the VF.
We have shown (Figure 2) that the spatiotemporal covariance structure specified in our
methodology successfully induces local neighborhood structure across the VF. The novelty
of employing the Garway-Heath angles in the form of a dissimilarity metric provides a
connection between the VF and the underlying optic disc, resulting in a neighborhood
structure on the VF that is representative of the RNFL. Other methods incorporated the
Garway-Heath angles into statistical models, either collapsed into regions of anatomical
interest (Betz-Stablein et al., 2013; Warren et al., 2016) or by VF location (Zhu et al., 2014),
but none allowed the effect to change dynamically. The dissimilarity metric parameter,
αtGH , dictates the VF spatial surface at each visit, allowing the neighborhood structure to
adapt alongside changes in DLS.
The results from applying our method to VF data (Section 5) demonstrated the added
benefit of using our methodology, in both the clinical and statistical frameworks. We
defined the diagnostic metric “ST CV” as the posterior mean of the CV of αtGH , and
showed that it is a significant predictor of clinically determined glaucoma progression while
being uncorrelated with standard VF trend-based metrics (“Mean CV”, PLR). Since “ST
CV” is independent of “Mean CV” and PLR, and each one is an effective predictor, there
is clinical utility to combining their diagnostic capability (i.e.,“ST CV” is not meant to
compete with “Mean CV” and PLR but should be used together). The “Space CV” metric
was not significantly associated with progression.
28
The significant association observed between “ST CV” and glaucoma progression was
statistically note-worthy, but taken in isolation had limited clinical implications. We showed
the clinical utility of “ST CV” in Section 5.5.2, where the operating characteristics of the
trend-based methods, both at the end of the study and in the early period, are improved
with the addition of “ST CV” (Table 2, Figure 4). This fundamental finding shows that
“ST CV” constitutes an alternate pathway for studying glaucoma progression using VF
data. This pathway is facilitated by the dissimilarity metric framework introduced by
the proposed methodology and consequently “ST CV” has a novel interpretation amongst
glaucoma progression diagnostic metrics. In particular, “ST CV” quantifies damage to the
optic disc over time as a function of stability on the spatial structure of the VF. It provides
a method for discussing underlying damage to the optic disc using VF data.
Our simulation study indicated that the presence of temporal correlation and cross-
covariance dependence impacted estimation of the posterior mean of the CV of αtGH . The
results (Table 3) illustrated superior bias, MSE, and EC for our proposed spatiotemporal
model over the spatial model of Lee and Mitchell (2011). These results imply that our
method provides a framework for more precisely estimating the CV of αtGH by smooth-
ing the αtGH and eliminating temporal noise and cross-covariance dependencies. These
results are consistent with studies that have shown when temporal correlation is ignored,
estimators are often biased and variances are poorly estimated (West, 1996).
In our implementation of the model for glaucoma data, we are not particularly interested
in the specific location of the spatial boundaries across the VF, unlike traditional boundary
detection applications. In isolation we do not believe those findings would be predictive
of glaucoma progression, but would only inform about the current level of vision loss for
a patient. Our results suggest that changes in these boundaries across time represent an
informative, innovative, and unique metric for diagnosing glaucoma progression. Using the
dissimilarity metric gives us the ability to directly quantify the boundary changes across
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time and therefore, to make clinical progression determinations for a patient.
The need for spatiotemporal boundary detection with a dissimilarity metric is also
driven by the unique features of our VF dataset. Using a more basic CAR structure with
fixed neighborhood adjacencies would result in ignoring the fact that these neighborhood
definitions are potentially changing across time due to disease progression. It would also
require us to fix the adjacencies a priori. On the other hand, using a point-referenced
geostatistical model with a spatiotemporal covariance function would result in ignoring
the inherent discreteness of the spatial domain, a grid overlaying the VF. Spatiotempo-
ral boundary detection with a dissimilarity metric represents an ideal blend between the
two methods by allowing for discreteness in the spatial domain and flexibility in defining
neighbors through use of a continuous covariate such as the Garway-Heath angles.
Finally, this work opens up numerous avenues for future statistical research. If data
are available, covariates can be incorporated in the observational model naturally via the
link function, g(ϑit) = xitβ + ϕit. Currently, the specification of the Leroux et al. (2000)
likelihood includes a µt in the mean structure, thus in order to identify the µt and β0 we
must either apply a constraint,
∑ν
t=0 µt = 0, or re-parameterize the likelihood to be a
function of only τt and αt. The incorporation of covariates is of particular importance in
disease mapping, where standard incidence rates are often mapped over varying risk factors
(Lee and Mitchell, 2013). Another natural extension to this approach includes generalizing
the separable temporal covariance to allow unique temporal decay parameters.
SUPPLEMENTARY MATERIAL
The supplementary materials contain details for implementing the MCMC sampler, in-
cluding derivation of full conditionals, along with prediction theory, additional sensitivity
analyses, and figures.
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